Remifentanil 5 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9FS8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,477
Award facts
- Contract value 100% obligated
- $11,477.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 5 mg vials, with a ceiling value of $11,477.08. This competitively awarded, firm fixed-price contract was established without set-aside provisions and is scheduled for completion by December 16, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contract awards demonstrate consistent capability to fulfill military and veteran healthcare system requirements through open competition. The Remifentanil delivery order supports the Defense Health Agency and other government healthcare systems by providing this potent opioid analgesic, commonly used in anesthesia and acute pain management within military medical facilities. The contract reflects AmerisourceBergen's ongoing role as a primary pharmaceutical supplier to the Department of Defense through the DLA supply chain network.
Quick answers
Who was awarded contract SPE2DR26F9FS8?
SPE2DR26F9FS8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F9FS8 worth?
The government has obligated $11,477 on SPE2DR26F9FS8.
Is contract SPE2DR26F9FS8 an order under another contract?
Yes. SPE2DR26F9FS8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9FS8 competed?
The extent of competition for SPE2DR26F9FS8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award